Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 53489-144

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 53489-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure (Spironolactone 02)

FDA Label Image

Container Label (Spironolactone 03)

Container Label (Spironolactone 03)
This is a prescription medication with NDC code 53489-144-01. It is a combination of Spironolactone and Hydrochlorothiazide tablets, which are used in the treatment of high blood pressure and fluid retention. The label instructs to dispense it in tight, light-resistant packaging. The usual dosage information is missing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.